The Ministry of Health and Prevention (MoHAP) in the UAE has withdrawn batch number ME051 of the API Sinocort Nasal Spray, a medication that's used to treat asthma and blocked airways.
The spray is manufactured by Amman Jordan Pharmaceutical Industries.
In a statement, MoHAP said the decision was made after a review of the batch showed it had failed to conform to the approved specifications.
Pharmacists and healthcare providers have been ordered to withdraw it from sale and return the drug to the suppliers
Users are advised to dispose of the batch and report any adverse reactions.
Dr. Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, and Chairman of the Supreme National Committee for Pharmacovigilance, urged people to contact them by email at ph@moh.gov.ae, through the E-system on MoHAP’s website, or the smart app ‘UAE RADAR.’
സോഷ്യൽ മീഡിയ ഉപയോഗിക്കുന്നതിനുള്ള പ്രായ പരിധി 15 ആയി നിശ്ചയിച്ച് യു എ ഇ
UAE sets 15 as minimum age for social media use
ആഗോളതലത്തിൽ സാമ്പത്തിക പ്രകടനത്തിൽ യു എ ഇയ്ക്ക് ഒന്നാം സ്ഥാനം;പ്രശംസിച്ച് ഷെയ്ഖ് മുഹമ്മദ്
H.H. Sheikh Mohammed lauds UAE for topping global list for economic achievements
No injuries after building fire on Dubai's Sheikh Zayed Road contained
'Dubai-it' initiative to embed Dubai’s work philosophy across generations
Dubai Police, RTA discuss measures to reduce heavy vehicle accidents
Dubai Holding's 'Gift It Forward' distributes repurposed items worth AED 22 million
